ThalesNano Launches Next Generation Version of Best Selling Flow Reactor: The H-Cube Pro(TM)
BUDAPEST, HUNGARY and LONDON and PRINCETON, NJ--(Marketwire - March 31, 2011) -
| Highlighted Links |
ThalesNano Website |
H-Cube Pro |
In addition to expanding upon the range and throughput of hydrogenation reactions, the H-Cube Pro™ is also completely forward-compatible with several upcoming low cost reactor modules to expand the chemistry capabilities still further. Chemists can look forward to utilizing other gases such as carbon monoxide, oxygen, or Syngas on the same instrument they already use for their hydrogenations. Another module allows homogeneous reactions to be performed at higher than microwave temperatures and pressures.
"With over 600 systems sold on 6 continents, the H-Cube® was the system that effectively brought flow chemistry into the mainstream chemistry laboratory," said Richard Jones, Director of Product Management. "Now with the H-Cube Pro™ and its companion reactor modules we're giving chemists even greater chemistry capabilities while maintaining and improving upon all of the major advantages of the original H-Cube®, such as safety and ease of use."
New H-Cube Pro™ abilities in full:
- Double the hydrogen production at all pressures
- Wider temperature range: 10-150°C
- Automated valve control with programmable timer
- Reactor module compatibility for extra chemistry functionality
- Real time, graphical reaction monitoring
- Method storage
- Software upgrades via the internet
- Built-in optimization software
For more information, please contact info@thalesnano.com.
About ThalesNano:
ThalesNano is the world leader in bench-top flow chemistry reactors. The company has the widest portfolio of bench-top continuous process instruments for the pharmaceutical, biotech, fine chemical, petroleum/biofuel, and education markets. Its R&D 100 award winning H-Cube® and scale-up system H-Cube Midi™ are used in hundreds of laboratories globally and have become the new industry standard for hydrogenation. Within three years from the original introduction of its flagship H-Cube® product, 20 out of the top 20 pharmaceutical companies have introduced and adopted the technology.